EPRX Eupraxia Pharmaceuticals Inc.
Company Analysis
Latest News
🟢 Eupraxia Pharmaceuticals is trading 5% up in after-hours trading; catalyst unconfirmed
Eupraxia Pharmaceuticals is trading 5.07% up at $8.50 after closing at $8.09 on September 16, 2026; the catalyst remains unconfirmed. - Recent...
🟢 Eupraxia Pharmaceuticals is trading 5.49% up today after August CPI data
Eupraxia Pharmaceuticals is trading 5.49% up at $8.46 as major U.S. indexes rise more than 1% following August CPI data, supporting broader risk appetite...
🟢 Eupraxia Pharmaceuticals is trading 6.42% up in pre-market after Nasdaq Global Select Market trading began
Eupraxia Pharmaceuticals is trading 6.42% up now at $8.78 after announcing on September 8, 2026, that its shares began trading on the Nasdaq Global Select...
🟢 Eupraxia Pharmaceuticals is trading 10.53% up today with no confirmed catalyst identified
Eupraxia Pharmaceuticals is trading at $8.29, up +10.53% on September 4, 2026, with no confirmed company-specific catalyst identified. - The Nasdaq Global...
🟢 Eupraxia Pharmaceuticals is trading 6.67% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 6.67% up at $8.00 on September 4, 2026; no new company-specific announcement or reliable source explicitly explains the...
🟢 Eupraxia Pharmaceuticals is trading 6.67% up in after-hours trading amid broader healthcare-sector strength
Eupraxia Pharmaceuticals is trading at $8.00, up 6.67%, amid broader healthcare strength and a risk-on market; company-specific causation remains...
🟢 Eupraxia Pharmaceuticals is trading 7.38% up today in after-hours trading amid broader healthcare-sector strength
Eupraxia Pharmaceuticals is trading 7.38% up now at $8.00 in after-hours trading, supported by broader healthcare-sector strength and a generally positive...
🟢 Eupraxia Pharmaceuticals is trading 12% up today as healthcare gains 1.37%
Eupraxia Pharmaceuticals is trading 11.83% up now at $7.09, with broader healthcare strength appearing to drive the move. - No clear company-specific...
🟢 Eupraxia Pharmaceuticals is trading 8% up today as Healthcare gains 1.37%
Eupraxia Pharmaceuticals is trading 8.04% up at $6.85, with the move appearing supported by broader healthcare-sector strength; no clear company-specific...
🔴 Eupraxia Pharmaceuticals is trading 5% down in pre-market with no clear company-specific catalyst
Eupraxia Pharmaceuticals is trading 5.21% down now at $6.01 after no clear company-specific catalyst was identified for September 2, 2026. - Its latest...
🟢 Eupraxia Pharmaceuticals is trading 13.78% up today in pre-market with no clear company-specific catalyst identified
Eupraxia Pharmaceuticals is trading 13.78% up at $7.35 after no clear company-specific catalyst was identified for September 1, 2026. • No September 1...
🔴 Eupraxia Pharmaceuticals is trading 5% down today
Eupraxia Pharmaceuticals is trading 5.02% down at $6.34, with no clear company-specific catalyst dated August 31 identified. - The decline extends the move...
🔴 Eupraxia Pharmaceuticals is trading 5.16% down today with no clear company-specific catalyst identified
Eupraxia Pharmaceuticals is trading at $6.98, down -5.16%, after no clear company-specific catalyst was identified for August 28, 2026. • No reliable August...
🟢 Eupraxia Pharmaceuticals is trading 5.92% up in pre-market with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 5.92% up in pre-market at $7.87, after rising from the August 26 close of $7.43, with no clear catalyst identified. - No...
🟢 Eupraxia Pharmaceuticals is trading 6.54% up today
Eupraxia Pharmaceuticals is trading 6.54% up at $7.17 based on the provided live price; the catalyst remains unconfirmed. - No new company-specific...
🟢 Eupraxia Pharmaceuticals is trading 12.33% up in pre-market — catalyst remains unconfirmed
Eupraxia Pharmaceuticals is trading 12.33% up at $7.56 in pre-market, based on the provided pre-market price versus the August 21, 2026 close of $6.73; the...
🔴 Eupraxia Pharmaceuticals is trading 7.88% down in pre-market with no company-specific catalyst identified
Eupraxia Pharmaceuticals is trading 7.88% down in pre-market at $6.20, with no confirmed company-specific catalyst identified. - The decline follows the...
🔴 Eupraxia Pharmaceuticals is trading 5% down in after-hours trading with no confirmed catalyst
Eupraxia Pharmaceuticals is trading 5.19% down in after-hours trading at $6.38, after falling from the August 21 regular-session close of $6.73; the catalyst...
🟢 Eupraxia Pharmaceuticals is trading 12.33% up in after-hours trading as Nasdaq Composite gains 1.24%
Eupraxia Pharmaceuticals is trading 12.33% up at $7.56 amid broader risk-on sentiment, with major U.S. indices finishing higher. - It closed at $6.73 on...
🟢 Eupraxia Pharmaceuticals is trading 10% up in after-hours trading amid broader risk-on sentiment
Eupraxia Pharmaceuticals is trading at $7.40, up 9.96% after closing at $6.73 on August 21, 2026, with the advance appearing most consistent with broader...